A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)
Clinical trial NCT03712228 · COMPLETED
Trial details
- NCT number
- NCT03712228
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-29
- Primary completion
- 2021-10-15
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.